PCN248 COST-UTILITY ANALYSIS OF FIRST-LINE THERAPY FOR ADVANCED AND METASTATIC PANCREATIC CANCER IN JAPAN.
Nov 1, 2019, 00:00 AM
10.1016/j.jval.2019.09.443
https://www.valueinhealthjournal.com/article/S1098-3015(19)32821-9/fulltext
Section Title :
Section Order :
10370
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)32821-9&doi=10.1016/j.jval.2019.09.443